Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction.
Stopped The study was terminated early due to a shortage of research and analytical personnel, which prevented the completion of the study as planned
Conditions
- Myocardial Infarction
- Angioplasty
Interventions
- DRUG: glycoprotein IIb/IIIa inhibitor (abciximab)
Sponsor
Seoul National University Hospital
Collaborators